Human B Cell Differentiation in a Model System
模型系统中的人类 B 细胞分化
基本信息
- 批准号:6398139
- 负责人:
- 金额:$ 22.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-08-05 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte CD antigens CD38 molecule CD40 molecule Epstein Barr virus biological signal transduction cell differentiation cell transformation child (0-11) cytokine receptors female gene expression gene mutation gene rearrangement helper T lymphocyte human subject immunodeficiency immunoglobulin genes leukocyte activation /transformation molecular pathology nuclear factor kappa beta patient oriented research tissue /cell culture transcription factor tumor necrosis factor alpha
项目摘要
DESCRIPTION (provided by applicant): We have identified a B-cell immunodeficiency that is distinguished by defective responses to CD4O and IL-4
signaling. B-cells from a young female patient (pt#l) have normal expression of
CD4O but are clearly deficient in a subset of CD4O-mediated functions including
early signals required for switch recombination. However, under specific in
vitro conditions pt#1 B-cells can regain functional responsiveness and undergo switching to express downstream antibody classes or isotypes. Our preliminary
data support a model whereby a signaling molecule or transcription factor in
the CD4O signal transduction pathway leading to NF-kB activation is affected.
This hypothesis is supported by our finding that pt#1 B-cells that are
transformed by Epstein-Barr virus (EBV) do not express CD23 a cell surface
molecule that is critically dependent on the viral latent infection membrane
protein LMP)1 and the subsequent activation of NF-kB by this protein.
Furthermore, LMP1 usurps the CD4O signaling pathway in order to maintain cell
transformation. Surprisingly, the pt#1 EBV-transformed B-cells loose their
transforming potential when grown in dilute culture conditions which also
suggests that LMP1 activity is compromised. Thus, three related lines of data
strongly suggest that the pt#1 defect is located in the CD4O signaling pathway
that leads to NF-kB activation and the transcription of specific cellular genes
involved in B-cell activation. We propose to use primary and transformed
B-cells from pt#1 to characterize the underlying defect Leading to B-cell
dysfunction. Efforts will be initially focused on the characterization of TRAF
and NF-kB expression and function which are the most proximal and distal
signaling events in the CD4O signaling cascade, respectively. The
EBV-transformed pt#l B-cells will be used to analyze signaling of LMP1 via the
CD4O pathway. Also, these cells will be used in transfection studies that are
aimed at complimenting the pt#l defect and in the analysis of of NF-kappaB
responsive promoters. Characterization of signaling pathways under the
different growth conditions will provide information into the relationship
between these signaling pathways and cell transformation. Finally, pt#l T-cells
have subtle defects in helper function provided to control B-cells that
manifest in inappropriate transcription of the heavy chain locus in response to
CD4O signaling alone. Experiments are proposed to understand the basis of this
functional defect.
描述(由申请人提供):我们已鉴定出一种B细胞 一种以对CD 4 O和IL-4的应答缺陷为特征的免疫缺陷
发信号。来自年轻女性患者(患者#1)的B细胞具有正常的
CD 40,但明显缺乏CD 40介导的功能,包括
切换重组所需的早期信号。然而,具体而言,
体外条件pt#1 B细胞可以重新获得功能性反应, 转换以表达下游抗体类别或同种型。我们的初步
数据支持一种模型,即信号分子或转录因子,
导致NF-κ B活化的CD 4 O信号转导途径受到影响。
这一假设得到了我们发现的支持,即pt#1 B细胞是
EB病毒(EBV)转化的细胞表面不表达CD 23 α
严重依赖于病毒潜伏感染膜的分子
蛋白LMP)1和随后通过该蛋白激活NF-κ B。
此外,LMP 1篡夺了CD 4 O信号传导途径,以维持细胞增殖。
转型令人惊讶的是,pt#1 EBV转化的B细胞失去了它们的
当在稀释培养条件下生长时的转化潜力,
表明LMP 1的活性受到了损害因此,三条相关的数据线
这强烈表明pt#1缺陷位于CD 4 O信号通路中
导致NF-κ B激活和特定细胞基因的转录
参与B细胞活化。我们建议使用原始和转换
来自患者#1的B细胞,用于表征导致B细胞的潜在缺陷
功能障碍最初的工作重点是确定TRAF的特征
和NF-kB的表达和功能,它们是最接近和最远的
CD 40信号级联中的信号事件。的
EBV转化的pt#1 B细胞将用于分析LMP 1通过免疫组织化学的信号传导。
CD 4 O途径。此外,这些细胞将用于转染研究,
旨在补充pt#l缺陷并分析NF-κ B
响应式启动子。信号通路的表征
不同的生长条件将提供信息,
这些信号通路和细胞转化之间的联系。最后,PT#1 T细胞
在控制B细胞的辅助功能方面有细微的缺陷,
表现为重链基因座的不适当转录,
单独的CD 40信号传导。提出实验来理解这一点的基础
功能缺陷
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LORI Ruth COVEY其他文献
LORI Ruth COVEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LORI Ruth COVEY', 18)}}的其他基金
Generation and characterization of CD40L-modified Mice
CD40L 修饰小鼠的生成和表征
- 批准号:
8580086 - 财政年份:2013
- 资助金额:
$ 22.94万 - 项目类别:
Generation and characterization of CD40L-modified Mice
CD40L 修饰小鼠的生成和表征
- 批准号:
8660640 - 财政年份:2013
- 资助金额:
$ 22.94万 - 项目类别:
ARE and non-ARE Pathways Regulating CD154 mRNA Stability
调节 CD154 mRNA 稳定性的 ARE 和非 ARE 途径
- 批准号:
6726748 - 财政年份:2003
- 资助金额:
$ 22.94万 - 项目类别:
HUMAN B CELL DIFFERENTIATION IN A MODEL SYSTEM
模型系统中的人类 B 细胞分化
- 批准号:
2672418 - 财政年份:1995
- 资助金额:
$ 22.94万 - 项目类别:
HUMAN B CELL DIFFERENTIATION IN A MODEL SYSTEM
模型系统中的人类 B 细胞分化
- 批准号:
2886969 - 财政年份:1995
- 资助金额:
$ 22.94万 - 项目类别:
Human B cell Differentiation in a Model system
模型系统中的人类 B 细胞分化
- 批准号:
6721150 - 财政年份:1995
- 资助金额:
$ 22.94万 - 项目类别:
HUMAN B CELL DIFFERENTIATION IN A MODEL SYSTEM
模型系统中的人类 B 细胞分化
- 批准号:
2004182 - 财政年份:1995
- 资助金额:
$ 22.94万 - 项目类别:
Human B cell Differentiation in a Model system
模型系统中的人类 B 细胞分化
- 批准号:
6472557 - 财政年份:1995
- 资助金额:
$ 22.94万 - 项目类别:
Human B cell Differentiation in a Model system
模型系统中的人类 B 细胞分化
- 批准号:
6624145 - 财政年份:1995
- 资助金额:
$ 22.94万 - 项目类别:
Human B cell Differentiation in a Model system
模型系统中的人类 B 细胞分化
- 批准号:
7023074 - 财政年份:1995
- 资助金额:
$ 22.94万 - 项目类别:
相似海外基金
Analysis of expression of Cd antigens in retinoblastoma, and its application for disease classification and therapeutic strategy
视网膜母细胞瘤中Cd抗原的表达分析及其在疾病分类和治疗策略中的应用
- 批准号:
25670726 - 财政年份:2013
- 资助金额:
$ 22.94万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research